ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study
Clinical Breast Cancer
◽
10.3816/cbc.2010.n.041
◽
2010
◽
Vol 10
(4)
◽
pp. 313-317
◽
Cited By ~ 3
Author(s):
Juan de la Haba-Rodriguez
◽
Rosario González Mancha
◽
Gumersindo Pérez Manga
◽
Enrique Aranda Aguilar
◽
José Manuel Baena Cañada
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
Related Documents
Cited By
References
A Clinical Phase II Study of a Non-Anthracycline Sequential Combination of Cisplatin-Vinorelbine Followed by Docetaxel as First-Line Treatment in Metastatic Breast Cancer
Oncology
◽
10.1159/000097945
◽
2006
◽
Vol 70
(5)
◽
pp. 330-338
◽
Cited By ~ 2
Author(s):
Ali I. Shamseddine
◽
Zaher K. Otrock
◽
Mohamad J. Khalifeh
◽
Hanan R. Yassine
◽
Maya Charafeddine
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
Clinical Phase
◽
Sequential Combination
◽
First Line Treatment
Download Full-text
Cisplatinum-Based Alternating Non-Cross-Resistant Chemotherapy as a First-Line Treatment in Metastatic Breast Cancer. A Phase II Study
Tumori Journal
◽
10.1177/030089169007600511
◽
1990
◽
Vol 76
(5)
◽
pp. 472-475
◽
Cited By ~ 2
Author(s):
Krsto Kolarić
◽
Rudolf Tomek
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial
Annals of Oncology
◽
10.1093/annonc/mdx772
◽
2018
◽
Vol 29
(3)
◽
pp. 661-668
◽
Cited By ~ 1
Author(s):
A. Gennari
◽
Z. Sun
◽
U. Hasler-Strub
◽
M. Colleoni
◽
M.J. Kennedy
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
Randomized Phase Ii
◽
Maintenance Schedules
◽
First Line Treatment
Download Full-text
Phase II Study of Gemcitabine and Bevacizumab As First-Line Treatment in Taxane-Pretreated, HER2-Negative, Locally Recurrent or Metastatic Breast Cancer
Clinical Breast Cancer
◽
10.1016/j.clbc.2012.07.004
◽
2012
◽
Vol 12
(5)
◽
pp. 322-330
◽
Cited By ~ 5
Author(s):
Rachel Borson
◽
Graydon Harker
◽
James Reeves
◽
Thaddeus Beck
◽
Steven Hager
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
Locally Recurrent
◽
First Line Treatment
Download Full-text
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer
Breast Cancer Research and Treatment
◽
10.1007/s10549-005-9030-x
◽
2005
◽
Vol 95
(1)
◽
pp. 45-53
◽
Cited By ~ 26
Author(s):
M. Venturini
◽
C. Bighin
◽
S. Monfardini
◽
F. Cappuzzo
◽
N. Olmeo
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
Multicenter Phase
◽
First Line Treatment
Download Full-text
Phase II study of gemcitabine (G) and bevacizumab (B) as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer (MBC): Interim safety analysis.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.1148
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. 1148-1148
Author(s):
R. Borson
◽
W. G. Harker
◽
J. E. Reeves
◽
J. Bromund
◽
L. Zhao
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Safety Analysis
◽
Line Treatment
◽
First Line
◽
Locally Recurrent
◽
First Line Treatment
Download Full-text
Final results of a phase II study of liposomal cisplatin -vinorelbine combination as first-line treatment in HER2/neu negative metastatic breast cancer.
Journal of Clinical Oncology
◽
10.1200/jco.2011.29.15_suppl.e11080
◽
2011
◽
Vol 29
(15_suppl)
◽
pp. e11080-e11080
Author(s):
F. S. Farhat
◽
S. Temraz
◽
J. G. Kattan
◽
K. Ibrahim
◽
N. Bitar
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
Sequential Doxorubicin and Docetaxel as First-Line Treatment in Metastatic Breast Cancer: A GEICAM-9801 Phase II Study
Breast Cancer Research and Treatment
◽
10.1023/a:1021158711030
◽
2003
◽
Vol 77
(1)
◽
pp. 1-8
◽
Cited By ~ 6
Author(s):
E. Alba
◽
N. Ribelles
◽
A. Antón
◽
R. Pérez-Carrión
◽
J.M. López-Vega
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer
Clinical Breast Cancer
◽
10.1016/j.clbc.2011.03.019
◽
2011
◽
Vol 11
(4)
◽
pp. 211-220
◽
Cited By ~ 23
Author(s):
Adam Brufsky
◽
Karen Hoelzer
◽
Thaddeus Beck
◽
Robert Whorf
◽
Mark Keaton
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
Randomized Phase Ii
◽
First Line Treatment
Download Full-text
Final results of a phase II study of bevacizumab plus docetaxel for the first-line treatment of metastatic breast cancer (TORI-B01)
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(08)70883-8
◽
2008
◽
Vol 6
(7)
◽
pp. 217
◽
Cited By ~ 1
Author(s):
S. Hurvitz
◽
H.J. Allen
◽
R.L. Moroose
◽
D. Chan
◽
C. Hagenstad
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close